Clinical Trial Update: Zileuton With or Without Celecoxib As Chemopreventive Agents in Smokers [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating zileuton with or without celecoxib as chemopreventive agents in smokers has completed; results were posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tobacco Use Disorder

Drugs mentioned

• Celecoxib (Celecoxib)
• Zileuton (zileuton)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Tobacco Use Disorder | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2015-04-02